0001849201-22-000001.txt : 20220523 0001849201-22-000001.hdr.sgml : 20220523 20220523140518 ACCESSION NUMBER: 0001849201-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 EFFECTIVENESS DATE: 20220523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurexis Therapeutics, Inc. CENTRAL INDEX KEY: 0001849201 IRS NUMBER: 844854116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-446621 FILM NUMBER: 22950876 BUSINESS ADDRESS: STREET 1: 12635 E MOUNTVIEW BLVD. STREET 2: SUITE 100 CITY: AURORA STATE: CO ZIP: 80045 BUSINESS PHONE: 4795712592 MAIL ADDRESS: STREET 1: 12635 E MOUNTVIEW BLVD. STREET 2: SUITE 100 CITY: AURORA STATE: CO ZIP: 80045 D 1 primary_doc.xml X0708 D LIVE 0001849201 Neurexis Therapeutics, Inc. 12635 E MOUNTVIEW BLVD. SUITE 100 AURORA CO COLORADO 80045 4795712592 DELAWARE None None Corporation true 2020 Robert Calvin Goforth 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Director Michael Artinger 12635 E. Mountainview Blvd. Suite 100 Aurora CO COLORADO 80045 Executive Officer Director K. Ulrich Bayer 12635 E. Mountainview Blvd. Suite 100 Aurora CO COLORADO 80045 Director Other Decline to Disclose 06b false 2022-05-18 false true false 0 None None None None N/A N/A Fayetteville AR ARKANSAS 72701 AR ARKANSAS false 200000 55000 145000 false 1 0 0 0 false Neurexis Therapeutics, Inc. Michael Artinger Michael Artinger Chief Executive Officer 2022-05-23